2-218661120-C-T
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM5PP3_StrongPP5_Very_Strong
The NM_001079866.2(BCS1L):c.133C>T(p.Arg45Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000889 in 1,461,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R45H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001079866.2 missense
Scores
Clinical Significance
Conservation
Publications
- Bjornstad syndromeInheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet, Ambry Genetics, ClinGen, G2P
- GRACILE syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
- Leigh syndromeInheritance: AR Classification: STRONG, LIMITED Submitted by: PanelApp Australia, ClinGen
- mitochondrial complex III deficiency nuclear type 1Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- mitochondrial complex III deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- renal tubulopathy-encephalopathy-liver failure syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001079866.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BCS1L | NM_001079866.2 | MANE Select | c.133C>T | p.Arg45Cys | missense | Exon 2 of 8 | NP_001073335.1 | ||
| BCS1L | NM_001257342.2 | c.133C>T | p.Arg45Cys | missense | Exon 3 of 9 | NP_001244271.1 | |||
| BCS1L | NM_001257343.2 | c.133C>T | p.Arg45Cys | missense | Exon 3 of 9 | NP_001244272.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BCS1L | ENST00000359273.8 | TSL:1 MANE Select | c.133C>T | p.Arg45Cys | missense | Exon 2 of 8 | ENSP00000352219.3 | ||
| BCS1L | ENST00000392109.5 | TSL:1 | c.133C>T | p.Arg45Cys | missense | Exon 3 of 9 | ENSP00000375957.1 | ||
| BCS1L | ENST00000392111.7 | TSL:1 | c.133C>T | p.Arg45Cys | missense | Exon 3 of 9 | ENSP00000375959.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251464 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461886Hom.: 0 Cov.: 33 AF XY: 0.00000688 AC XY: 5AN XY: 727244 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 45 of the BCS1L protein (p.Arg45Cys). This variant is present in population databases (rs121908575, gnomAD 0.004%). This missense change has been observed in individual(s) with mitochondrial complex III deficiency (PMID: 12910490). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 6168). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BCS1L protein function with a positive predictive value of 95%. This variant disrupts the p.Arg45 amino acid residue in BCS1L. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 28322498). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 20727375, 12910490, 20518024, 19508421, 38821922, 34662929)
Pili torti-deafness syndrome Pathogenic:1
Pili torti-deafness syndrome;C1864002:GRACILE syndrome;C3541471:Mitochondrial complex III deficiency nuclear type 1 Pathogenic:1
Mitochondrial complex III deficiency nuclear type 1 Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at